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Abstract
Objective:  To  evaluate  the  nutritional  status  of  children  with  persistent  cholestasis  and  to
compare the  anthropometric  indices  between  children  with  and  without  liver  cirrhosis  and
children  with  and  without  jaundice.
Methods:  Children  with  persistent  cholestasis,  i.e.  increased  direct  bilirrubin  or  changes  in
the canalicular  enzyme  gamma-glutamyl  transferase  (GGT),  were  included.  The  anthropomet-
ric measures  were  weight  (W),  height  or  length  (H),  arm  circumference  (AC),  triceps  skinfold
thickness (TST),  arm  muscle  circumference  (AMC),  and  body  mass  index  (BMI).
Results: Ninety-one  children  with  cholestasis,  with  current  median  age  of  12  months,  were
evaluated. W/age  (A)  and  H/A  indices  below  −2  Z-scores  were  observed  in  33%  and  30.8%
of patients,  respectively.  Concerning  the  W/H  index  and  BMI,  only  12%  and  16%  of  patients,
respectively,  were  below  −2  Z-scores.  Regarding  AC,  43.8%  of  89  evaluated  patients  had  some
depletion.  Observing  the  TST,  64%  of  patients  had  depletion,  and  71.1%  of  the  45  evaluated
patients  had  some  degree  of  depletion  regarding  the  ACM  index.
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Conclusion:  Evaluation  using  weight  in  patients  with  chronic  liver  diseases  may  overestimate
the nutritional  status  due  to  visceromegaly,  subclinical  edema,  or  ascites.  Indices  that  correlate
weight and  height,  such  as  W/H  and  BMI,  may  also  not  show  depletion  because  of  the  chronic
condition in  which  there  are  depletion  of  both  weight  and  height.  TST,  AC,  and  ACM  are  param-
eters that  better  estimate  nutritional  status  and  should  be  part  of  the  management  of  patients
with liver  diseases  and  cholestasis.
© 2015  Sociedade  Brasileira  de  Pediatria.  Published  by  Elsevier  Editora  Ltda.  All  rights  reserved.
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Avaliac¸ão  nutricional  de  crianc¸as com  colestase  crônica
Resumo
Objetivo:  Avaliar  a  situac¸ão  nutricional  de  crianc¸as  com  colestase  persistente  e  comparar  os
índices antropométricos  entre  crianc¸as  com  e  sem  cirrose  hepática  e  crianc¸as  com  e  sem
icterícia.
Métodos: Foram  incluídas  crianc¸as  com  colestase  persistente,  ou  seja,  aumento  da  bilirru-
bina direta  ou  alterac¸ões  na  enzima  canalicular,  gamaglutamiltransferase  (GGT).  As  medidas
antropométricas  foram  peso  (P),  estatura  ou  altura  (A),  circunferência  do  brac¸o (CB),  espessura
da prega  cutânea  do  tríceps  (TST),  circunferência  muscular  do  brac¸o (CMB)  e  índice  de  massa
corporal (IMC).
Resultados:  Foram  avaliadas  noventa  e  uma  crianc¸as  com  colestase,  com  idade  média  de  12
meses. 33%  e  30,8%  dos  pacientes  apresentaram  índices  P/I  e  A/I  com  escore  Z  abaixo  de
-2, respectivamente.  Com  relac¸ão  ao  índice  P/A  e  IMC,  somente  12%  e  16%  dos  pacientes,
respectivamente,  apresentaram  escore  Z  abaixo  de  -2.  Com  relac¸ão  à  CB,  43,8%  de  89  pacientes
avaliados apresentaram  alguma  deplec¸ão.  Observando  a  TST,  64%  dos  pacientes  apresentaram
deplec¸ão, e  71,1%  dos  45  pacientes  avaliados  apresentaram  algum  grau  de  deplec¸ão  com  relac¸ão
ao índice  de  CMB.
Conclusão:  A  avaliac¸ão  do  peso  em  pacientes  com  doenc¸as  hepáticas  crônicas  poderá  super-
estimar a  situac¸ão  nutricional  devido  a  visceromegalia,  edema  subclínico  ou  ascite.  Os  índices
que correlacionam  peso  e  altura,  como  P/A  e  IMC,  também  podem  não  mostrar  deplec¸ão  de-
vido à  doenc¸a  crônica  em  que  há  deplec¸ão  tanto  do  peso  quanto  da  altura.  A  TST,  BC  e  CMB
são parâmetros  que  estimam  melhor  a  situac¸ão  nutricional  e  devem  fazer  parte  do  manejo  de
pacientes com  doenc¸as  hepáticas  e  colestase.
© 2015  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  Todos  os  direitos
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holestasis  is  a  common  manifestation  of  liver  disease
n  children,  which  occurs  in  approximately  65%  of  these
atients.  It  is  the  impairment  of  bile  ﬂow  due  to  biliary  tract
bstruction  or  impairment  of  bile  acid  uptake,  conjugation,
r  excretion.1,2 Cholestasis  impairs  the  nutritional  status  of
hese  children.3 Malnutrition  leads  to  increased  morbidity
nd  mortality  in  patients  with  chronic  liver  disease.  Barches
t  al.4 reported  that  malnutrition  in  the  pre-transplant
eriod  is  associated  with  longer  hospital  stay  and  spend-
ng.  Besides,  Moukarzel  et  al.5 showed  a  narrow  correlation
etween  nutritional  status  and  outcomes  of  liver  transplant
n  children.  In  that  study,  children  with  Z-score  below  −2
tandard  deviations  had  a  higher  incidence  of  infection  in
he  post-transplant  period,  more  surgical  complications,  and
igher  mortality.
Approximately  60%  of  children  with  chronic  liver  disease
re  under  the  expected  weight  and  height  for  their  age.6,7
n  appropriate  nutritional  support  could  prevent  the  fast
rogression  of  the  underlying  disease,  with  improvement
f  the  immune  function.6,8,9 Nutritional  evaluation  of  these
hildren  is  essential,  but  the  weight  can  be  overestimated
T
H
Fn  cases  of  visceromegaly,  ascites,  and  peripheral  edema;
herefore,  when  considered  separately,  this  evaluation  is
ot  a  good  parameter  to  identify  malnutrition.  The  most
ensitive  measures  to  determine  the  nutritional  status  in
hronic  liver  disease  are  arm  circumference  (AC)  and  tri-
eps  skinfold  (TST).10 A  meticulous  physical  exam,  several
hysical  anthropometric  measures,  and  individualized  com-
lementary  tests  are  indispensable.  Because  malnutrition
s  a  consequence  of  chronic  cholestasis,  knowledge  on  the
mpact  of  this  condition  in  committed  children  may  help  in
ecommending  early  nutritional  intervention.
This  study  aimed  to  evaluate  the  nutritional  status  of  chil-
ren  diagnosed  with  cholestasis  followed  at  the  Pediatric
epatology  Unit  of  this  institution  and  to  correlate  the  food
ntake  with  nutritional  status.  In  addition,  anthropometric
ndices  were  compared  between  patients  with  and  without
iver  cirrhosis  and  children  with  and  without  jaundice.
atients and methodshis  case  series  study  was  carried  out  at  the  Pediatric
epatology  Unit  of  the  Hospital  das  Clínicas,  Universidade
ederal  de  Minas  Gerais  (UFMG),  Brazil,  from  January  of
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2009  to  December  of  2013.  Children  with  clinical  and/or
laboratory  persistent  cholestasis  were  included.  Persistent
cholestasis  was  deﬁned  as  increased  direct  bilirubin  (direct
bilirubin  of  more  than  20%  of  the  total  bilirubin  or  more
than  2  mg/dL,  when  the  levels  are  higher  than  5  mg/dL;  or
direct  bilirubin  greater  than  1  mg/dL  when  total  bilirubin  is
less  than  5  mg/dL)  or  the  raise  of  the  canalicular  enzyme,
gamma-glutamyl  transferase  (GGT),  above  the  reference
value  for  age.11 All  patients  underwent  liver  biopsy,  which
was  indicated  on  the  patient  initial  evaluation  for  differen-
tial  diagnosis  of  cholestasis  and/or  during  the  course  of  the
disease  for  monitoring  histopathological  ﬁndings.
The  study  was  approved  by  the  Ethics  Committee  of  the
institution  (protocol  number  ETIC  310/08).
Anthropometric  measures  collected  were  weight  (W),
length  or  height  (H),  arm  circumference  (AC),  triceps  skin-
fold  thickness  (TST),  arm  muscle  circumference  (AMC),  and
body  mass  index  (BMI).  The  analyzed  variables  were:  gender,
age  in  months  at  the  time  of  clinical  evaluation,  classiﬁca-
tion  as  having  cirrhosis  or  not  (based  on  histopathology),
classiﬁcation  of  cirrhosis  by  the  Child--Pugh  criteria,  labo-
ratory  tests  (albumin  and  bilirubin),  and  the  caloric  intake
through  the  72-h  food  record.  Clinical  and  laboratory  data
were  obtained  at  the  same  time  of  nutritional  evaluation,
i.e., in  a  single  moment.  Food  intake  was  recorded  for  72  h
after  nutritional  evaluation.
Children  younger  than  2  years  and  weighing  up  to
16  kg  were  measured  in  horizontal  anthropometer  (Pedi-
atric  Anthropometric  Ruler;  NutriVida®,  São  Paulo,  Brazil)
and  weighed,  without  clothes  or  diaper,  on  an  electronic,
digital,  and  calibrated  scale  (Digital  Infant  Scale;  Welmy®,
São  Paulo,  Brazil).  The  vertical  stadiometer  (Vertical  sta-
diometer;  Physical  Nutrivida®,  São  Paulo,  Brazil)  and  an
electronic,  digital,  and  calibrated  platform  (Digital  Scale;
Balmak®,  São  Paulo,  Brazil)  were  used  to  measure  children
older  than  2  years.  Patients  were  evaluated  barefoot  and,
usually,  only  with  underwear.  The  equipment  was  checked
before  use.  These  measures  were  classiﬁed  through  the  2008
SISVAN  (Food  and  Nutrition  Surveillance  Systems)12 protocol
per  life  phase,  adapted  from  the  World  Health  Organiza-
tion  (WHO)13;  the  cutoff  points  used  had  the  WHO  charts  as
reference  and  were  calculated  by  the  WHO  Anthro,  version
3.2.2.14
An  inelastic  tape  was  used  to  measure  the  AC,  and  a
plicometer  was  used  for  the  measurement  of  TST.  These
parameters  were  calculated  and  classiﬁed  based  on  WHO
standards  according  to  age  and  height.15 The  measures  were
performed  on  the  right  side  of  the  child.  Patients  younger
than  2  years  were  evaluated  in  standing  position,  on  the
lap  of  the  mother  or  guardian.  AC  was  measured  at  midway
between  the  acromion  and  the  inferior  border  of  the  olecra-
non.  TST  was  measured  at  the  same  position  of  AC,  i.e., the
posterior  face  of  the  arm.  The  measurement  was  carried  out
following  longitudinal  axis  of  the  limb.  Three  measures  were
performed  at  the  same  position,  with  a  difference  of  three
seconds  between  each  other,  and  the  mean  of  the  values
was  calculated  to  avoid  possible  errors,  as  recommended  by
the  literature.12Patients  were  classiﬁed  based  on  WHO  Anthro14 cal-
culation  by  using  the  following  values:  severe  depletion
(less  than  70%),  moderate  depletion  (between  70%  and
80%),  mild  depletion  (between  80%  and  90%),  eutrophy
o
i
i
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between  90%  and  110%),  overweight  (between  110%
nd  120%),  and  obesity  (more  than  120%).  The  for-
ulas  for  these  calculations  were:  adequacy  of  AC
%)  =  [obtained  AC  (cm)/AC50  percentile]  ×  100;  adequacy
f  TST  (%)  =  [obtained  TST  (cm)/TST  50  percentile]  ×  100;
nd  AMC  (cm)  =  AC  (cm)  −  3.14  ×  TST  (cm).
AMC  values,  according  to  gender  and  age,  were  compared
ith  reference  values  of  the  National  Health  and  Nutri-
ion  Examination  Survey  (NHANES),  expressed  in  percentile
ables  by  Frisancho,  starting  from  1  year  of  age.16 Patients
ounger  than  1  year  were  excluded  from  this  analysis  due  to
he  lack  of  reference  values  for  this  age  group.
After  clinical  evaluation,  the  caregiver  of  the  child
eported  all  food  ingested  by  the  child  for  three  consecu-
ive  days.  The  number  of  days,  time,  kind,  and  amount  of
ood  ingested  by  the  child  were  informed.  For  children  who
ere  exclusively  breast-fed,  the  mother  took  note  of  breast-
eeding  time  to  estimate,  according  to  age  and  suckling
ime,  the  volume  of  milk  ingested  by  the  infant.
The  calculation  of  calorie-protein  intake  was  carried  out
y  the  software  DietPro  version  4.0  (Agromídia  Softwares®,
inas  Gerais,  Brazil),17 as  well  as  the  Food  Composi-
ion  Table18 and  the  home  measures  table,19 including  the
acronutrients  carbohydrates,  proteins,  and  lipids.  Then,
he  daily  recommendations  of  calories  were  calculated
ccording  to  age  by  the  FAO/WHO/UN  1985  report,  based
n  calories  requirement  for  total  energy  consumption  plus
rowth  of  breast-fed  children.20
Data  were  analyzed  by  the  software  Epi  Info  version  6.04
Centers  for  Disease  Control  and  Prevention,  Atlanta,  USA).
ontinuous  variables  with  non-Gaussian  distribution  were
hown  as  medians  and  interquartile  range  (IQ  25th--75th)
nd  compared  with  the  nonparametric  Kruskal--Wallis  test.
he  distribution  of  dichotomous  variables  was  compared  by
he  chi-squared  test,  with  Yates  correction,  or  two-tailed
isher’s  exact  test,  if  necessary.  The  probability  was  consid-
red  signiﬁcant  when  p  <  0.05.
esults
inety-one  children  with  initial  diagnosis  of  cholestasis  were
valuated.  The  median  age  was  12  months,  and  52.7%  were
ale.  The  etiologies  of  cholestasis  were:  biliary  atresia
n  31  patients  (34.1%),  idiopathic  neonatal  hepatitis  in  25
27.5%),  multifactorial  cholestasis  in  eight  (8.8%),  Alagille
yndrome  in  eight  (8.8%),  deﬁciency  of  alpha-1-antitrypsin
n  six  (6.6%),  hypoplasia  of  bile  ducts  in  four  (4.4%),  and
ther  diagnoses  in  six  patients  (6.6%).  Twenty-ﬁve  patients
27.5%)  showed  cirrhosis  on  the  histopathological  exam  (18
ith  biliary  atresia  and  seven  with  idiopathic  neonatal  hep-
titis);  11  patients  were  classiﬁed  as  Child--Pugh  class  A
44%),  12  as  class  B  (48%),  and  two  as  class  C  (8%).  Seventy
atients  (76.9%)  had  jaundice  with  abnormally  high  levels
f  bilirubin,  GGT,  and  aminotransferase,  while  21  children
23.1%)  had  normal  levels  of  bilirubin,  without  jaundice,  but
ith  increased  levels  of  GGT.
Clinical,  laboratory,  nutritional,  and  anthropometric  dataf  the  patients  are  shown  in  Tables  1  and  2. The  follow-
ng  indexes  were  calculated:  weight/age  (W/A);  height/age
ndex  (H/A);  weight/height  (W/H);  body  mass  index  (BMI).
or  some  data,  marked  with  an  asterisk,  median  and
200  da  Silva  FV  et  al.
Table  1  Clinical,  laboratory,  nutritional,  and  anthropometric  data  of  children  diagnosed  as  neonatal  cholestasis  in  general  and
divided according  to  the  presence  of  cirrhosis.
General  (91  children)  With  cirrhosis
(25  children)
Without  cirrhosis
(66  children)
Age  (months)a 12  [6.0  to  40.0]  11  [5.0  to  38.5]  12  [6  to  40.5]
Visceromegaly,  n  (%)  61  (67%)  24  (96%)  37  (56.1%)
Splenomegaly,  n  (%)  42  (46.2%)  21  (84%)  21  (31.8%)
Hepatomegaly,  n  (%)  57  (62.6%)  22  (88%)  35  (53%)
Hepatosplenomegaly,  n  (%)  38  (41.8%)  17  (68%)  19  (28.8%)
Ascites, n  (%)  7  (7.7%)  5  (20%)  2  (3%)
Albumin (g/dL) 4.1  [3.8  to  4.5]  4  [3.47  to  4.40]  4.2  [3.8  to  4.5]
Z-score W/Aa −1.10  [−2.40  to  0.36] −1.39  [−2.72  to  0.12] −0.93  [−2.2  to  0.54]
Z-score H/Aa −0.80  [−2.30  to  −0.03] −1.6  [−2.57  to  −0.62] −0.70  [−2.4  to  0.30]
Z-score W/Ha −0.05  [−1.30  to  0.80]  −0.52  [−1.85  to  0.76]  −0.03  [−1.23  to  0.86]
Z-score BMIa −0.24  [−1.40  to  0.90]  −0.52  [−2.24  to  0.87]  0.03  [−1.30  to  0.87]
Z-score TSTa −0.40  [−1.70  to  0.80]  −1.35  [−2.65  to  0.30]  −0.12  [−1.43  to  1.00]
Dietary recorda 91.4%  [79.0%  to  104.6%]  92.9%  [72.9%  to  105.8%]  90.5%  [80.8%  to  103.4%]
Dietary record,  n  (%)
<60%  2  (2.2%)  1  (4%)  1  (1.5%)
60% to  <95%  50  (55%)  13  (52%)  37  (56.1%)
95% to  105%  17  (18.7%)  4  (16%)  13  (19.7%)
105% to  <140%  20  (22%)  7  (28.0%)  13  (19.7%)
>140% 2  (2.2%)  0  (0.0%)  2  (3.0%)
W/A, weight/age index; H/A, height/age index; W/H, weight/height index; BMI, body mass index; TST, triceps skinfold thickness.
a For some data, median and interquartile range (IQ 25th--75th) were used; for dietary record the calculation used was: (dietary intake
record/recommended for age) × 100.
Table  2  Clinical,  laboratory,  nutritional,  and  anthropometric  data  of  children  diagnosed  as  neonatal  cholestasis  in  general  and
divided according  to  the  presence  of  jaundice.
General  (91  children)  With  jaundice
(70  children)
Without  jaundice
(21  children)
Age  (months)a 12  [6.0  to  40.0]  10  [5.0--34.25]  31  [10--56.5]
Cirrhosis 25  22  3
Visceromegaly,  n  (%)  61  (67%)  51  (72.9%)  10  (47.6%)
Splenomegaly,  n  (%)  42  (46.2%)  37  (52.9%)  05  (23.8%)
Hepatomegaly,  n  (%)  57  (62.6%)  48  (68.6%)  09  (42.9%)
Hepatosplenomegaly,  n  (%)  38  (41.8%)  29  (41.4%)  09  (42.9%)
Ascites, n  (%)  7  (7.7%)  7  (10%)  0  (0%)
Total bilirubin  (md/dL)  2.1  [0.5  to  5.68]  3.4  [1.7  to  7.45]  0.5  [0.25  to  0.7]
Direct bilirubin  (mg/dL)  1.4  [0.2  to  3.3]  2.0  [1.37  to  5.6]  0.2  [0.1  to  0.32]
GGT (U/L)  495  [244  to  587]  402  [180  to  686.8]  234  [180  to  554]
Albumin (g/dL)  4.1  [3.8  to  4.5]  4.1  [3.7  to  4.45]  4.2  [4.0  to  4.6]
Z-score W/Aa −1.10  [−2.40  to  0.36]  −1.52  [−2.5  to  −0.95]  0.36  [−0.46  to  1.14]
Z-score H/Aa −0.80  [−2.30  to  −003]  −1.15  [−2.53  to  −0.28]  −0.12  [−1.18  to  0.44]
Z-score W/Ha −0.05  [−1.30  to  0.80]  −0.71  [−1.4  to  0.45]  0.83  [0.02  to  1.3]
Z-score BMIa −0.24  [−1.40  to  0.90]  −0.52  [−2.24  to  0.87]  0.87  [0.11  to  1.13]
Z-score TSTa −0.40  [−1.70  to  0.80]  −0.71  [−1.41  to  0.67]  0.15  [−0.39  to  1.08]
Dietary recorda 91.4%  [79.0%  to  104.6%]  89.9%  [77.6%  to  105.6%]  93.14%  [86.2%  to  100.8%]
Dietary record,  n  (%)
<60%  2  (2.2%)  1  (1.4%)  1  (4.8%)
60% to  <95%  50  (55%)  39  (55.7%)  11  (52.4%)
95% to  105%  17  (18.7%)  11  (15.7%)  6  (28.6%)
105% to  140%  20  (22%)  17  (24.3%)  3  (14.3%)
>140% 2  (2.2%)  2  (2.9%)  0  (0%)W/A, weight/age index; H/A, height/age index; W/H, weight/height i
a For some data, median and interquartile range (IQ 25th--75th) were
record/recommended for age) × 100.ndex; BMI, body mass index; TST, triceps skinfold thickness.
 used; for dietary record the calculation used was: (dietary intake
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interquartile  range  (IQ  25th--75th)  were  used.  Dietary
intake  was  calculated  using  the  formula  (dietary  intake
record/recommended  for  age)  ×  100.
Regarding  nutritional  intake,  57.2%  of  the  91  patients
were  below  95%  of  the  recommended  calories,  with  no
statistically  signiﬁcant  difference  between  those  with  and
without  cirrhosis  (p  =  0.32)  and  between  children  with  and
without  jaundice  (p  =  0.80).  When  comparing  patients  with
ingestion  below  95%  of  the  recommended  with  patients  with
nutritional  depletion,  no  statistically  signiﬁcant  differences
were  observed  on  AC  (p  =  0.14),  TST  (p  =  0.09),  and  AMC
(p  =  0.09).
Table  3  presents  the  nutritional  classiﬁcation  based  on
anthropometric  indices  in  the  entire  group  and  in  patients
stratiﬁed  according  to  the  presence  of  cirrhosis.  There  was
no  statistically  signiﬁcant  difference  between  patients  with
and  without  cirrhosis  for  the  W/A  (p  =  0.48),  H/A  (p  =  0.92),
W/H  (p  =  0.28),  and  BMI  (p  =  0.07)  indices,  as  well  as  for  TST
and  AMC  (p  =  0.07  for  TST;  and  83.3%  vs.  66.7%,  p  =  0.24
for  AMC).  Regarding  AC,  there  was  a  statistically  signiﬁ-
cant  difference  between  patients  with  and  without  cirrhosis
(p  =  0.006).
Table  4  shows  the  nutritional  classiﬁcation  based  on
anthropometric  indices  in  the  entire  group  and  in  patients
stratiﬁed  according  to  the  presence  of  jaundice.  No  differ-
ences  were  observed  in  the  comparison  between  the  data  of
children  with  and  without  jaundice  for  W/A  (p  =  0.18),  H/A
(p  =  0.92),  W/H  (p  =  0.45),  BMI  (p  =  0.07),  and  AMC  (p  =  0.08).
Regarding  the  presence  of  any  degree  of  depletion  in  AC
and  TST,  patients  with  jaundice  had  signiﬁcantly  higher
frequency  of  depletion  in  both  parameters  than  those  with-
out  jaundice  (p  =  0.045  and  p  =  0.001,  respectively).  When
comparing  patients  with  nutritional  depletion  by  TST  with
those  with  low  weight  for  height  or  age,  a  statistically
signiﬁcant  difference  was  observed  for  both  parameters
(p  =  0.000).
Regarding  the  evaluation  of  AC,  39  (43.8%)  of  89  patients
had  some  degree  of  depletion.  Conversely,  only  11  (12.3%)
of  89  patients  had  low  W/H  (p  =  0.001)  and  only  28  (31.5%)
had  low  W/A  (p  = 0.000).
Similarly,  when  assessing  AMC,  32  (71.1%)  of  45  patients
had  some  degree  of  depletion,  while  only  two  (4.4%)  had
low  W/H  (p  =  0.000)  and  only  seven  (15.6%)  of  45  patients
had  low  W/A  (p  = 0.000).
Discussion
Nutritional  evaluation  of  these  children  is  essential,  but
it  has  several  challenges.  The  presence  of  visceromegaly,
ascites,  and  peripheral  edema  can  limit  the  use  of  weight,
the  most  common  index  for  nutritional  evaluation.  There-
fore,  a  meticulous  physical  exam,  several  anthropometric
measures,  and  individualized  complementary  tests  are  indis-
pensible  for  a  reliable  nutritional  evaluation  of  these
patients.  TST  and  AC  measures  are  more  reliable,  as
these  parameters  do  not  consider  the  weight  and  could  be
extremely  important  in  clinical  practice,  allowing  for  an
early  diagnosis  of  nutritional  deﬁcits.  The  estimate  of  fat
deposits  through  TST  and  of  protein  content  by  AMC  and  AC
are  complementary  data  that  allow  for  an  accurate  nutri-
tional  evaluation  of  these  patients.3,21,22
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In  the  present  study,  one-third  of  patients  showed  W/A
nd  H/A  indices  under  −2  Z-scores.  Considering  the  W/H
ndex,  only  12.1%  of  patients  had  Z-score  lower  than  −2;  in
elation  to  the  BMI,  the  percentage  was  16.5%.  This  demon-
trates  that  W/H  should  always  be  used  in  combination  with
/A,  since  the  proportional  deﬁcits  in  weight  and  height  are
ot  identiﬁed  by  this  ﬁrst  method.  It  also  shows  that  BMI  is
ot  a  good  measure  of  body  composition  in  this  population.
Similarly,  in  another  Brazilian  study  with  22  children  and
dolescents  with  cholestasis,  23.8%  and  33.3%  of  patients
ere  malnourished  according  to  W/A  and  H/A  criteria,
espectively,  and  none  of  them  was  under  −2  Z-scores  in
elation  to  W/H  index.23
Nutritional  inadequacy  was  higher  when  AC,  TST,  and  AMC
ndices  were  used.  Regarding  AC,  43.9%  of  patients  had  some
egree  of  depletion;  TST,  46.2%;  and  AMC,  71.1%.  Although
he  W/A  and  H/A  indices  revealed  that  almost  one-third  of
atients  had  nutritional  depletion,  AC,  TST,  and  AMC  indi-
ated  a  higher  frequency  of  malnutrition.
AMC  probably  showed  a  greater  proportion  of  patients
ith  inadequate  nutritional  when  compared  with  AC  and
ST,  due  to  the  age  of  the  evaluated  patients  in  this  study.
MC  had  only  been  reported  in  patients  older  than  1  year,
.e.,  with  a  longer  time  of  evolution  of  cholestatic  disease.
Schneider  et  al.24 reported  in  their  study  on  children
ith  cirrhosis  that  the  index  that  best  reﬂected  the  nutri-
ional  risk  was  TST,  conﬁrming  that  it  can  measure  the  body
at  mass,  showing  the  length  and  severity  of  malnutrition.
herefore,  this  measure  is  very  important  in  the  nutritional
valuation  of  these  patients.  Sokol  et  al.25 emphasized  the
mportance  of  TST  and  AC  measures  as  more  accurate  meth-
ds  to  evaluate  fat  deposits  and  protein  content  in  patients
ith  chronic  liver  disease.
Regarding  W/H  and  BMI,  an  important  ﬂaw  occurs,  which
an  be  explained  at  least  in  part  by  the  chronic  pattern
f  nutritional  impairment  observed  in  these  patients  when
oth  weight  and  height  are  involved.  This  reinforces  that  the
se  of  conventional  anthropometric  indices,  such  as  W/A,
/A,  W/H,  and  BMI,  may  overestimate  the  nutritional  status
f  patients  with  cholestasis,  even  when  edema  and  ascites
re  not  evident.  In  addition,  visceromegaly  contributes  to
eight  increase  of  these  patients,  which  compromises  the
se  of  indices  that  include  weight.2
The  inadequacy  of  these  indices  can  also  be  noticed  when
omparing  patients  with  and  without  jaundice,  and  with
nd  without  liver  cirrhosis.  No  statistical  differences  were
etected  between  these  subgroups  for  W/A,  H/A,  W/H  or
MI.  On  the  other  hand,  the  evaluation  of  AC  showed  sta-
istically  signiﬁcant  difference  between  patients  with  and
ithout  cirrhosis  and  between  children  with  and  without
aundice.
The  evaluation  of  TST  and  AMC  has  not  shown  statisti-
al  difference  between  patients  with  and  without  cirrhosis.
his  can  be  explained  by  the  fact  that  the  patient  assess-
ent  has  been  performed  in  a  single  moment.  Summing  up,
n  the  majority  of  cases,  malnutrition  was  only  detected
hen  the  evaluation  was  not  restricted  to  weight  and  height
easures.
The  frequency  of  nutritional  depletion  based  on  AC  and
ST  evaluation  was  similar,  indicating  similar  depletion  of
at  and  lean  mass.  This  ﬁnding  differed  from  the  results
eported  by  Cardoso  et  al.,21 who  observed  higher  initial  loss
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Table  3  Nutritional  classiﬁcation  based  on  anthropometric  indices  in  the  whole  group  patients  and  stratiﬁed  according  to  the
presence of  cirrhosis.
Index  General  (91
patients),  n  (%)
With  cirrhosis  (25
patients),  n  (%)
Without  cirrhosis
(66  patients),  n  (%)
Height/age
Very  low  16  (17.6%)  5  (20.0%)  11  (16.7%)
Low 12  (13.2%)  3  (12.0%)  9  (13.6%)
Adequate 63  (69.2%)  17  (68.0%)  46  (69.7%)
Weight/age
Very low  11  (12.1%)  4  (16.0%)  7  (10.6%)
Low 19  (20.9%)  5  (20.0%)  14  (21.2%)
Adequate 59  (64.8%)  15  (60.0%)  44  (66.7%)
High 2  (2.2%) 1  (4.0%) 1  (1.5%)
Weight/height
Very low  6  (6.6%)  2  (8%)  4  (6.1%)
Low 5  (5.5%)  3  (12%)  2  (15.2%)
Adequate 66  (72.50%)  16  (64%)  50  (75.8%)
High 14  (15.4%)  4  (25%)  10  (15.2%)
Body mass  index
Very  low  7  (7.7%)  3  (12%)  4  (6.1%)
Low 8  (8.8%)  4  (16%)  4  (6.1%)
Adequate 56  (61.5%)  12  (48%)  44  (66.7%)
Overweight  risk  19  (20.8%)  5  (20%)  14  (21.2%)
Overweight  1  (1.1%)  1  (4.0%)  0  (0.0%)
Arm circumferencea
Severe  depletion  3  (3.4%)  1  (4.0%)  2  (3.1%)
Moderate depletion  7  (7.9%)  5  (20.0%)  2  (3.1%)
Mild depletion  29  (32.6%)  11  (44.0%)  18  (28.1%)
Eutrophy 42  (47.2%)  7  (28.0%)  35  (54.7%)
Overweight  8  (8.9%)  1  (4.0%)  7  (10.9%)
Obesity 0  (0.0%)  0  (0.0%)  0  (0%)
Triceps skinfold  thickness
Severe  depletion  21  (23.1%)  12  (48.0%)  9  (13.6%)
Moderate depletion  15  (16.5%)  2  (8.0%)  13  (19.7%)
Mild depletion  6  (6.6%)  2  (8.0%)  4  (6.0%)
Eutrophy 17  (18.7%)  4  (16.0%)  13  (19.7%)
Overweight  11  (12.1%)  1  (4.0%)  10  (15.1%)
Obesity 21  (23.1%)  4  (16.0%)  17  (25.8%)
Arm muscle  circumferenceb
Severe  depletion  6  (13.3%)  2  (16.7%)  4  (12.1%)
Moderate depletion  10  (22.2%)  4  (33.3%)  6  (18.2%)
Mild depletion  16  (35.6%)  4  (33.3%)  12  (36.4%)
Eutrophy 13  (28.9%)  2  (16.7%)  11  (33.3%)
Note: For evaluation of height/age index, Z-score was categorized as very low (Z-score < −3); low (Z-score ≥ −3 and <−2); adequate
(Z-score ≥ −2). For the weight/age index, as very low (Z-score < −3); low (Z-score ≥ −3 and <−2); adequate (Z-score ≥ −2 and ≤+2);
high (Z-score > +2). For weight/height, as very low (Z-score < −3); low (Z-score ≥ −3 and <−2); adequate (Z-score ≥ −2 and ≤+1); high (Z-
score > +1). For body mass index, Z-score was categorized as very low (Z-score < −3); low (Z-score ≥ −3 and <−2); adequate (Z-score ≥ −2
and ≤+1); overweight risk (>Z-score +1 and ≤Z-score +2) and (Z-score > +2 and <+3). For arm circumference, triceps skinfold thickness,
and arm muscle circumference, the used classiﬁcation was severe depletion: <70% of expected; moderate depletion: ≥70% and <80%
of expected; mild depletion: ≥80% and <90% of expected; eutrophy: ≥90% and ≤110% of expected; overweight: >110% and ≤120% of
o
s
w
mexpected; and obesity: >120% of expected.
a The total number of patients evaluated in this index was 89.
b The total number of patients evaluated in this index was 45.f  fat.  This  difference  can  be  attributed  to  patients’  age,
ince  in  the  study  of  Cardoso  et  al.21 patients  were  younger
ith  mean  age  of  nine  months.  AMC  seemed  to  overesti-
ate  malnutrition,  since  71.1%  of  patients  had  some  degree
o
6
t
cf  depletion,  with  83.3%  among  patients  with  cirrhosis  and
6.7%  among  the  group  without  cirrhosis.  The  AMC  evalua-
ion  performed  only  in  patients  older  than  one  year  of  age
an  explain  these  results.
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Table  4  Nutritional  classiﬁcation  based  on  anthropometric  indices  in  the  whole  group  patients  and  stratiﬁed  according  to  the
presence of  jaundice.
Index  General  (91
patients),  n  (%)
With  jaundice  (70
patients),  n  (%)
Without  jaundice
(21  patients),  n  (%)
Height/age
Very  low  16  (17.6%)  14  (20%)  2  (9.5%)
Low 12  (13.2%)  11  (15.7%)  1  (4.8%)
Adequate 63  (69.2%)  45  (64.3%)  18  (85.7%)
Weight/age
Very low  11  (12.1%)  9  (12.9%)  2  (9.5%)
Low 19  (20.9%)  17  (24.3%)  2  (9.5%)
Adequate 59  (64.8%)  42  (60%)  17  (81%)
High 2  (2.2%) 2  (2.9%) 0  (0%)
Weight/height
Very low  6  (6.6%)  5  (7.1%)  1  (4.8%)
Low 5  (5.5%)  5  (7.1%)  0  (0%)
Adequate 66  (72.5%)  53  (75.7%)  13  (61.9%)
High 14  (15.4%)  7  (10%)  7  (33.3%)
Body mass  index
Very  low  7  (7.7%)  6  (8.6%)  1  (4.8%)
Low 8  (8.8%)  8  (11.4%)  0  (0%)
Adequate 59  (64.8%)  48  (68.6%)  11  (52.4%)
Overweight  risk  16  (17.6%)  7  (10%)  9  (42.9%)
Overweight  1  (1.1%)  1  (1.4%)  0  (0%)
Arm circumferencea
Severe  depletion  3  (3.4%)  3  (4.4%)  0  (0%)
Moderate depletion  7  (7.9%)  7  (10.3%)  0  (0%)
Mild depletion  29  (32.6%)  24  (35.3%)  5  (23.8%)
Eutrophy 42  (47.2%)  29  (42.6%)  13  (61.9%)
Overweight  8  (8.9%)  5  (7.4%)  3  (14.3%)
Obesity 0  (0.0%)  0  (0%)  0  (0%)
Triceps skinfold  thickness
Severe  depletion  21  (23.1%)  19  (27.1%)  2  (9.5%)
Moderate depletion  15  (16.5%)  15  (21.4%)  0  (0%)
Mild depletion  6  (6.6%)  5  (7.1%)  1  (4.8%)
Eutrophy 17  (18.7%)  8  (11.4%)  9  (42.9%)
Overweight  11  (12.1%)  8  (11.4%)  3  (14.3%)
Obesity 21  (23.1%)  15  (21.4%)  6  (28.6%)
Arm muscle  circumferenceb
Severe  depletion  6  (13.3%)  6  (20%)  0  (0%)
Moderate depletion  10  (22.2%)  6  (20%)  4  (26.7%)
Mild depletion  16  (35.6%)  12  (40%)  4  (26.7%)
Eutrophy 13  (28.9%)  6  (20%)  7  (46.7%)
Note: For evaluation of height/age index, Z-score was categorized as very low (Z-score < −3); low (Z-score ≥−3 and <−2); adequate
(Z-score ≥ −2). For weight/age index, as very low (Z-score < −3); low (Z-score ≥−3 and <−2); adequate (Z-score ≥−2 and ≤+2); high
(Z-score > +2). For weight/height, as very low (Z-score < −3); low (Z-score ≥−3 and <−2); adequate (Z-score ≥−2 and ≤+1); high (Z-
score >+1). For body mass index, Z-score was categorized as very low (Z-score < −3); low (Z-score ≥−3 and <−2); adequate (Z-score ≥−2
and ≤+1); overweight risk (>Z-score +1 and ≤Z-score +2) and (Z-score >+2 and <+3). For arm circumference, triceps skinfold thickness
and arm muscle circumference, the used classiﬁcation was severe depletion: <70% of expected; moderate depletion: ≥70% and <80%
of expected; mild depletion: ≥80% and <90% of expected; eutrophy: ≥90% and ≤110% of expected; overweight: >110% and ≤120% of
expected; and obesity: >120% of expected.
a The total number of patients evaluated in this index was 89.
b The total number of patients evaluated in this index was 45.Regarding  dietary  intake,  57.2%  of  91  patients  ingested
lower  than  95%  of  diet  recommendations,  without  signiﬁcant
differences  between  patients  with  and  without  cirrhosis
(p  =  0.32)  and  between  children  with  and  without  jaundice
(
n
c
wp  =  0.80);  this  ﬁnding  could  be  related  to  the  fact  that
utritional  evaluation  was  done  in  a single  moment.  When
omparing  the  patients  with  low  intake  of  calories  to  those
ith  some  degree  of  nutritional  depletion  identiﬁed  through
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he  AC,  TST,  or  AMC,  there  was  no  statistical  difference.
hese  methods  proved  to  be  similar  and  important  in  the
utritional  assessment  of  patients  with  chronic  cholestatic
iver  disease.  Accordingly,  Cardoso  et  al.21 showed  even
igher  indices  of  inadequate  diet  (90%)  when  food  intake
as  evaluated  qualitatively  and  quantitatively.  This  is  even
ore  worrying,  since  caloric  intake  should  be  optimized  to
p  140%  of  the  expected.  Considering  this  recommendation,
nly  2.2%  of  patients  had  appropriate  caloric  intake.  After
his  evaluation,  the  families  were  orientated  regarding  food
ntake  and  dietetic  needs,  but  the  results  of  the  interven-
ions  have  not  been  studied  yet.
The  authors  are  aware  of  the  limitations  of  the  present
tudy.  The  most  important  of  them  is  that  nutritional  assess-
ent  was  performed  in  a  single  moment,  which  makes
omparisons  between  patients  with  or  without  cirrhosis  and
ith  or  without  jaundice  difﬁcult,  since  the  patients  were
t  different  stages  in  the  disease  course.  Another  limita-
ion  was  related  to  the  dietary  record,  because,  even  if
ata  collection  is  strict,  this  record  can  always  be  faulty,
ince  it  depends  on  patient’s  memory  and  cooperation.  In
ddition,  an  important  issue  is  that  the  nutritional  assess-
ent  was  performed  by  the  same  dietitian;  ideally,  it  would
e  performed  by  two  dietitians  with  a  subsequent  compar-
son  of  the  results.  Nevertheless,  the  authors  believe  these
imitations  do  not  decrease  the  importance  of  the  present
ndings.
In  conclusion,  the  use  of  weight  for  nutritional  evaluation
ay  underestimate  the  detection  of  malnutrition  in  patients
ith  chronic  liver  diseases  due  to  visceromegaly,  subclini-
al  edema,  and/or  ascites.21 The  anthropometric  indices
hat  consider  weight  and  height,  such  as  W/H  and  BMI,  may
lso  not  reveal  the  real  degree  of  depletion  attributable
o  chronic  clinical  condition  of  these  patients,  in  which
oth  weight  and  height  are  impaired.  TST  and  AC  measures
ppear  to  be  more  accurate  parameters  for  nutritional  eval-
ation  of  patients  with  liver  diseases  and  cholestasis.
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